Delivery Order SPE2DB22D2006-SPE2DB25FV7PC

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $2,663.71 and is set to expire on August 1, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,116,842 units of the drug Ondansetron ODT 4 mg tablets. The award has a ceiling value of $5,097.98 and an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a Delivery Order contract award valued at $14,554.06 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of Ondansetron ODT 4 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of January 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract has a ceiling value of $1,896.59 and a period of performance through November 5, 2024. It is structured as a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract has a firm fixed price of $6,946.82 and a completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, with a ceiling value of $6,305.60 and a completion date of January 3, 2025. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ondansetron ODT 4 mg tablets for a total ceiling value of $5,488.01. The order has a firm fixed price and an ultimate completion date of August 27, 2024. AmerisourceBergen has a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for providing a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,168.56 Firm Fixed Price contract is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $17,404.42 and an ultimate completion date of August 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for providing the pharmaceutical products to the government under this contract. This award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,416 units of the prescription drug Ondansetron ODT 8 mg tablets. The contract has a ceiling value of $1,735.60 and a period of performance through August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7PC
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $5,909.59 and is for the supply of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price, delivery order contract that runs through January 14, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/14/25, 10:28 AM